Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment

Renal cell carcinoma (advanced) - axitinib: review decision - December 2014 information

Renal cell carcinoma (advanced) - axitinib: appendix A - GE Decision paper November 2014

Renal cell carcinoma (advanced) - axitinib: equality impact assessment

Renal cell carcinoma (advanced) - axitinib [ID518]: 2nd final appraisal determination  information

Renal cell carcinoma (advanced) - axitinib [ID518]: evaluation report information

Renal cell carcinoma (advanced) - axitinib [ID518]: evaluation report (PDF 1.66 MB)

Renal cell carcinoma (advanced) - axitinib [ID518]: final appraisal determination document

Renal cell carcinoma (advanced) - axitinib: appraisal consultation 2

Renal cell carcinoma (advanced) - axitinib: appraisal consultation document 2 information

Renal cell carcinoma (advanced) - evaluation report information

Renal cell carcinoma (advanced) - axitinib: final scope (post-appeal)

Renal cell carcinoma (advanced) - axitinib: final matrix (post-appeal)

Renal cell carcinoma (advanced) - axitinib: response to consultee and commentator comments on the updated scope and provisional matrix (post-appeal) 

Renal cell carcinoma (advanced) - axitinib: appeal information

Renal cell carcinoma (advanced) - axitinib: appeal decision

Renal cell carcinoma (advanced) - axitinib: appeal decision (PDF 287 KB)

Renal cell carcinoma (advanced) - axitinib: appeal announcement information

Renal cell carcinoma (advanced) - axitinib: Pfizer appeal documents

Renal cell carcinoma (advanced) - axitinib: Pfizer appeal documents (PDF 917 KB)

Renal cell carcinoma (advanced) - axitinib: James Whale Fund for Kidney Cancer appeal documents

Renal cell carcinoma (advanced) - axitinib: James Whale Fund for Kidney Cancer appeal documents (PDF 457 KB)

Renal cell carcinoma (advanced) - axitinib: Kidney Cancer UK appeal documents

Renal cell carcinoma (advanced) - axitinib: Kidney Cancer UK appeal documents (PDF 964 KB)

Renal cell carcinoma (advanced) - axitinib: Royal College of Physicians appeal documents

Renal cell carcinoma (advanced) - axitinib: Royal College of Physicians appeal documents (PDF 732 KB)

Renal cell carcinoma (advanced) - axitinib: final appraisal determination information

Renal cell carcinoma (advanced) - axitinib: final appraisal determination document

Renal cell carcinoma (advanced) - axitinib: final appraisal determination document (PDF 243 KB)

Renal cell carcinoma (advanced) - axitinib: response to consultee, commentator and public comments on the Appraisal Consultation Document

Renal cell carcinoma (advanced) - axitinib: response to consultee, commentator and public comments on the Appraisal Consultation Document (PDF 253 KB)

Renal cell carcinoma (advanced) - axitinib: consultee and commentator comments on the ACD

Renal cell carcinoma (advanced) - axitinib: Pfizer

Renal cell carcinoma (advanced) - axitinib: Pfizer (PDF 707 KB)

Renal cell carcinoma (advanced) - axitinib: Commissioning Support Appraisal Service

Renal cell carcinoma (advanced) - axitinib: Commissioning Support Appraisal Service (PDF 154 KB)

Renal cell carcinoma (advanced) - axitinib: James Whale Fund for Kidney Cancer

Renal cell carcinoma (advanced) - axitinib: James Whale Fund for Kidney Cancer (PDF 49 KB)

Renal cell carcinoma (advanced) - axitinib: Kidney Cancer UK

Renal cell carcinoma (advanced) - axitinib: Kidney Cancer UK (PDF 16 KB)

Renal cell carcinoma (advanced) - axitinib: Hawkins

Renal cell carcinoma (advanced) - axitinib: Hawkins (PDF 58 KB)

Renal cell carcinoma (advanced) - axitinib: comments on the ACD received from the public through the NICE website

Renal cell carcinoma (advanced) - axitinib: comments on the ACD received from the public through the NICE website (PDF 38 KB)

Renal cell carcinoma (advanced) - axitinib: manufacturer revised PAS submission template

Renal cell carcinoma (advanced) - axitinib: manufacturer revised PAS submission template (PDF 352 KB)

Renal cell carcinoma (advanced) - axitinib: manufacturer additional evidence, updated basecase and PAS

Renal cell carcinoma (advanced) - axitinib: manufacturer additional evidence, updated basecase and PAS (PDF 127 KB)

Renal cell carcinoma (advanced) - axitinib: ERG review of additional evidence, updated basecase and PAS

Renal cell carcinoma (advanced) - axitinib: appraisal consultation

Renal cell carcinoma (advanced) - axitinib: appraisal consultation document information

Renal cell carcinoma (advanced) - axitinib: Evaluation report

Renal cell carcinoma (advanced) - axitinib: Pre-meeting briefing

Renal cell carcinoma (advanced) - axitinib: Pre-meeting briefing (PDF 636 KB)

Renal cell carcinoma (advanced) - axitinib: Evidence Review Group report

Renal cell carcinoma (advanced) - axitinib: Evidence Review Group report (PDF 2.2 MB)

Renal cell carcinoma (advanced) - axitinib: Erratum to the Evidence Review Group report

Renal cell carcinoma (advanced) - axitinib: Erratum to the Evidence Review Group report (PDF 768 KB)

Renal cell carcinoma (advanced) - axitinib: Addendum to the Evidence Review Group report

Renal cell carcinoma (advanced) - axitinib: Addendum to the Evidence Review Group report (PDF 260 KB)

Renal cell carcinoma (advanced) - axitinib: Evidence Review Group report - factual accuracy check

Renal cell carcinoma (advanced) - axitinib: Evidence Review Group report - factual accuracy check (PDF 129 KB)

Renal cell carcinoma (advanced) - axitinib: Manufacturer submission

Renal cell carcinoma (advanced) - axitinib: Manufacturer submission - Pfizer

Renal cell carcinoma (advanced) - axitinib: Manufacturer submission - Pfizer (PDF 4.75 MB)

Renal cell carcinoma (advanced) - axitinib: Department of Health letter confirming PAS

Renal cell carcinoma (advanced) - axitinib: Department of Health letter confirming PAS (PDF 44 KB)

Renal cell carcinoma (advanced) - axitinib: PAS submission

Renal cell carcinoma (advanced) - axitinib: PAS submission (PDF 429 KB)

Renal cell carcinoma (advanced) - axitinib: Clarification

Renal cell carcinoma (advanced) - axitinib: NICE clarification letter

Renal cell carcinoma (advanced) - axitinib: NICE clarification letter (PDF 150 KB)

Renal cell carcinoma (advanced) - axitinib: Manufacturer response to the NICE clarification letter

Renal cell carcinoma (advanced) - axitinib: Manufacturer response to the NICE clarification letter (PDF 298 KB)

Renal cell carcinoma (advanced) - axitinib: Patient group, professional group and NHS organisation submission statements

Renal cell carcinoma (advanced) - axitinib: James Whale Fund for Kidney Cancer

Renal cell carcinoma (advanced) - axitinib: James Whale Fund for Kidney Cancer (PDF 116 KB)

Renal cell carcinoma (advanced) - axitinib: Kidney Cancer UK

Renal cell carcinoma (advanced) - axitinib: Kidney Cancer UK (PDF 73 KB)

Renal cell carcinoma (advanced) - axitinib: Rarer Cancers Foundation

Renal cell carcinoma (advanced) - axitinib: Rarer Cancers Foundation (PDF 135 KB)

Renal cell carcinoma (advanced) - axitinib: NHS Norfolk

Renal cell carcinoma (advanced) - axitinib: NHS Norfolk (PDF 70 KB)

Renal cell carcinoma (advanced) - axitinib: Expert written personal statements

Renal cell carcinoma (advanced) - axitinib: Brown and Hawkins (joint statement)

Renal cell carcinoma (advanced) - axitinib: Brown and Hawkins (joint statement) (PDF 108 KB)

Renal cell carcinoma (advanced) - axitinib: Hanlon

Renal cell carcinoma (advanced) - axitinib: Hanlon (PDF 177 KB)

Renal cell carcinoma (advanced) - axitinib: Lowe

Renal cell carcinoma (advanced) - axitinib: response to consultee and commentator comments on the draft scope and provisional matrix (pre-appeal)

Renal cell carcinoma (advanced) - axitinib: final matrix (pre-appeal)

Renal cell carcinoma (advanced) - axitinib: final scope (pre-appeal)

Renal cell carcinoma (advanced) - axitinib: Appendix B - draft scope for consultation (pre-referral) - September 2011 

Renal cell carcinoma (advanced) - axitinib: Appendic C - provisional matrix (pre-referral) - September 2011